NSCLC Immunotherapy Efficacy and Antibiotic Use

Journal Of Thoracic Oncology
29 Jun, 2020 ,

Lise Lurienne et.al. to assess the impact of antibiotic use on the survival of patients diagnosed with NSCLC and treated with Immune checkpoint inhibitors. The researchers concluded that progression-free survival and overall survival were difficult to compare between studies owing to heterogeneity and the multiple confounding factors identified, further studies are needed to strengthen the understanding of this phenomenon.